Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2020 Volume 19 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2020 Volume 19 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Protective effects of fisetin against myocardial ischemia/reperfusion injury

  • Authors:
    • Lihui Long
    • Xuliang Han
    • Xingming Ma
    • Kai Li
    • Linjie Liu
    • Juanni Dong
    • Bei Qin
    • Kelin Zhang
    • Kuan Yang
    • Honglin Yan
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710077, P.R. China, Department of Pharmacology, College of Pharmacy of Xi'an Medical University, Xi'an, Shaanxi 710061, P.R. China, Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710077, P.R. China
    Copyright: © Long et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3177-3188
    |
    Published online on: March 6, 2020
       https://doi.org/10.3892/etm.2020.8576
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The underlying mechanism of the myocardial protective effect of fisetin was studied in a rat ischemia/reperfusion injury model. Sprague‑Dawley rats were randomly assigned to seven groups and pretreated with different solutions by gavage administration. A rat model of cardiac ischemia/reperfusion injury was established. Plasma levels of Von Willebrand factor (vWF) were determined by ELISA, flow cytometry was used to determine the level of cardiomyocyte apoptosis and 2,3,5‑triphenyltetrazolium staining was used to determine the size of myocardial infarcts. Hematoxylin and eosin‑stained sections of myocardial tissues were examined for pathological changes. Expressions of nuclear factor (NF)‑κB and matrix metallopeptidase 9 (MMP‑9) were measured by immunohistochemistry. Compared with the model group, rats pretreated with fisetin, quercetin and aspirin showed significant prolongation of clotting time, prothrombin time, thrombin time and activated partial thromboplastin time. Fisetin treatment better maintained the integrity of myocardial fibers and nuclear integrity, reduced the percentage of apoptotic myocardial cells, inhibited expression of NF‑κB, decreased the loss of MMP‑9 and reduced nuclear translocation of NF‑kB. Rats pretreated with fisetin also demonstrated a significant decrease in plasma levels of vWF. In addition, the protective effect of fisetin on myocardial cells was found to be dose dependent.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Wong CX, Sun MT, Lau DH, Brooks AG, Sullivan T, Worthley MI, Roberts-Thomson KC and Sanders P: Nationwide trends in the incidence of acute myocardial infarction in Australia, 1993-2010. Am J Cardiol. 112:169–173. 2013.PubMed/NCBI View Article : Google Scholar

2 

Kramarow E, Lubitz J and Francis R Jr: Trends in the coronary heart disease risk profile of middle-aged adults. Ann Epidemiol. 23:31–34. 2013.PubMed/NCBI View Article : Google Scholar

3 

Braga JR, Tu JV, Austin PC, Chong A, You JJ, Farkouh ME, Ross HJ and Lee DS: Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circ Heart Fail. 6:193–202. 2013.PubMed/NCBI View Article : Google Scholar

4 

Neri M, Riezzo I, Pascale N, Pomara C and Turillazzi E: Ischemia/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists. Mediators Inflamm. 4(7018393)2017.PubMed/NCBI View Article : Google Scholar

5 

Portt L, Norman G, Clapp C, Greenwood M and Greenwood MT: Anti-apoptosis and cell survival: A review. Biochim Biophys Acta. 1813:238–259. 2011.PubMed/NCBI View Article : Google Scholar

6 

Wei Q, Yin Y, Xi M, Zhou D, Zhu Y, Guan Y, Guo C, Wang Y, Duan J and Wen A: Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro. J Tradit Chin Med. 33:85–91. 2013.PubMed/NCBI View Article : Google Scholar

7 

Wang Y, Zhang ZZ, Wu Y, Zhan J, He XH and Wang YL: Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. Exp Ther Med. 5:315–319. 2013.PubMed/NCBI View Article : Google Scholar

8 

Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, et al: Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population. Clin Appl Thromb Hemost. 18:72–78. 2012.PubMed/NCBI View Article : Google Scholar

9 

Sinha R, Srivastava S, Joshi A, Joshi UJ and Govil G: In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercet in: Role of localization and intermolecular interaction in model membrane. Eur J Med Chem. 79:102–109. 2014.PubMed/NCBI View Article : Google Scholar

10 

Chen PY, Ho YR, Wu MJ, Huang SP, Chen PK, Tai MH, Ho CT and Yen JH: Cytoprotective effects of fisetin against hypoxia-induced cell death in PC12 cells. Food Funct. 6:287–296. 2014.PubMed/NCBI View Article : Google Scholar

11 

Pasparakis M: Regulation of tissue homeostasis by NF-kappaB signalling: Implications for inflammatory diseases. Nat Rev Immunol. 9:778–788. 2009.PubMed/NCBI View Article : Google Scholar

12 

Li JL, Chen XL and Sheng LP: Research of the latest brain injury and MMP-9. J Gen Pract. 271–272. 2011.

13 

Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M and Beissel J: Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail. 12:66–72. 2006.PubMed/NCBI View Article : Google Scholar

14 

Nićiforović N, Mihailović V, Masković P, Solujić S, Stojković A and Pavlović Muratspahić D: Antioxidant activity of selected plant species; potential new sources of natural antioxidants. Food Chem Toxicol. 48:3125–3130. 2010.PubMed/NCBI View Article : Google Scholar

15 

Valianou L, Stathopoulou K, Karapanagiotis I, Magiatis P, Pavlidou E, Skaltsounis AL and Chryssoulakis Y: Phytochemical analysis of young fustic (Cotinus coggygria heartwood) and identification of isolated colourants in historical textiles. Anal Bioanal Chem. 394:871–882. 2009.PubMed/NCBI View Article : Google Scholar

16 

Savikin K, Zdunic G, Jankovic T, Stanojkovic T, Juranic Z and Menkovic N: In vitro cytotoxic and antioxidative activity of Cornus mas and Cotinus coggygria. Nat Prod Res. 23:1731–1739. 2009.PubMed/NCBI View Article : Google Scholar

17 

Tripathi R, Samadder T, Gupta S, Surolia A and Shaha C: Anticancer activity of a combination of Cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Mol Cancer Ther. 10:255–268. 2011.PubMed/NCBI View Article : Google Scholar

18 

Cui EX, Long LH, Zhang JQ, Shao HY and Liu LL: Extracorporeal anticoagulant and dissolving thrombus effects of Fisetin and Quercetin. J Chin Med Mat. 32:1111–1113. 2009.(In Chinese).

19 

Park HH, Lee S, Oh JM, Lee MS, Yoon KH, Park BH, Kim JW, Song H and Kim SH: Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol Res. 55:31–37. 2007.PubMed/NCBI View Article : Google Scholar

20 

Sengupta B, Banerjee A and Sengupta PK: Interactions of the plant flavonoid fisetin with macromolecular targets: Insights from fluorescence spectroscopic studies. J Photochem Photobiol B. 80:79–86. 2005.PubMed/NCBI View Article : Google Scholar

21 

Ivanova D, Gerova D, Chervenkov T and Yankova T: Polyphenols and antioxidant capacity of Bulgarian medicinal plants. J Ethnopharmacol. 96:145–150. 2005.PubMed/NCBI View Article : Google Scholar

22 

Sengupta B, Banerjee A and Sengupta PK: Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Lett. 570:77–81. 2004.PubMed/NCBI View Article : Google Scholar

23 

Yang Y and Qian ZY: Effect of crocetin on platelet aggregation in rats. Chin J Nat Med. 5:374–378. 2007.

24 

Cui EX, Long LH, Liu J and Cao YX: Anti-coagulation of cotinus coggygria scop. J Chin Med Mat. 30:202–205. 2007.(In Chinese).

25 

Mennander AA, Vuohelainen V, Aanismaa RS, Narkilahti S, Paavonen T and Tarkka M: Sildenafil after cardiac arrest and infarction; an experimental rat model. Scand Cardiovasc J Suppl. 47:58–64. 2013.PubMed/NCBI View Article : Google Scholar

26 

Jin J, Chen F, Wang Q, Qiu Y, Zhao L and Guo Z: Inhibition of TNF-α by cyclophosphamide reduces myocardial injury after ischemia-reperfusion. Ann Thorac Cardiovasc Surg. 19:24–29. 2013.PubMed/NCBI View Article : Google Scholar

27 

Ding YF, Zhang MM and He RR: Ischemic preconditioning reduces cardiomyocytic apoptosis in rabbit heart in vivo. Sheng Li Xue Bao. 52:220–224. 2000.PubMed/NCBI(In Chinese).

28 

Long LH, Cao YX, Ma Z and Liu J: Anticoagulant, anti-aggregation and antithrombotic effects of a novel hexapeptide. J Pharm Pharmacol. 63:1454–1461. 2011.PubMed/NCBI View Article : Google Scholar

29 

Maulik N, Sasaki H, Addya S and Das DK: Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett. 485:7–12. 2000.PubMed/NCBI View Article : Google Scholar

30 

Galang N, Sasaki H and Maulik N: Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicol. 148:111–118. 2000.PubMed/NCBI View Article : Google Scholar

31 

Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD and Sherman MY: Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem. 275:38088–38094. 2000.PubMed/NCBI View Article : Google Scholar

32 

Yu-hui H, Yun F, Fen J and Xing L: Study about cardiomyocyte apoptosis in myocardial ischemic-reperfusion injury of rats and NF-κB p65, iNOS expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 26:868–870. 2010.PubMed/NCBI(In Chinese).

33 

Yang F, Zhao WL, Mi QY, Xie LP, Liu Z, Zhang W, Li XZ, Huang Y and Ji Y: Assessment of myocardial ischemia-reperfusion injury with two different staining methods. Acta Univ Med Nanjing (Nat Sci). 29:1055–1058. 2009.

34 

Fantinelli JC, Gonzalez Arbelaez LF, Perez Nunez IA and Mosca SM: Protective effects of N-(2-mercaptopropionyl)-glycine against ischemia-reperfusion injury in hypertrophied hearts. Exp Mol Pathol. 94:277–284. 2013.PubMed/NCBI View Article : Google Scholar

35 

Chen J, Petrov A, Yaniz-Galende E, Liang L, de Haas HJ, Narula J and Hajjar RJ: The impact of pressure overload on coronary vascular changes following myocardial infarction in rats. Am J Physiol Heart Circ Physiol. 304:H719–H728. 2013.PubMed/NCBI View Article : Google Scholar

36 

Cao Z, Ren D, Ha T, Liu L, Wang X, Kalbfleisch J, Gao X, Kao R, Williams D and Li C: CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: Involving activation of PI3K/Akt signaling. Biochim Biophys Acta. 1832:96–104. 2013.PubMed/NCBI View Article : Google Scholar

37 

Bacaksiz A, Teker ME, Buyukpinarbasili N, Inan O, Tasal A, Sonmez O, Erdogan E, Turfan M, Akdemir OC and Ertas G: Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats? Eur Rev Med Pharmacol Sci. 17:269–275. 2013.PubMed/NCBI

38 

Yu YP, Xu QQ, Zheng MZ and Wei EQ: Light transmission measurement of focal ischemic cerebral infarction in mice. Zhejiang Da Xue Xue Bao Yi Xue Ban. 31:91–93. 2002.PubMed/NCBI(In Chinese).

39 

Kou YY, Zha XD, Li YF and Ge RL: The antioxidative effect of Sanwei Tanxiang powder on rats' hearts against myocardial ischemia and reperfusion injury. Zhong Yao Cai. 31:1013–1015. 2008.PubMed/NCBI(In Chinese).

40 

Zhang Q, Rui X and Cai D: Protective effect of Ginaton on rat liver microcirculation disturbance following liver xenotransplantation. Zhonghua Yi Xue Za Zhi. 80:706–708. 2000.PubMed/NCBI(In Chinese).

41 

Ashraf HS, Hussain I, Siddiqui AA, Ibrahim MN and Khan MU: The outcome of living related kidney transplantation with multiple renal arteries. Saudi J Kidney Dis Transpl. 24:615–619. 2013.PubMed/NCBI View Article : Google Scholar

42 

Burton TM, Lacey M, Liu F, Yu Y, Monsalvo ML, Lang K and Sander S: One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel. J Med Econ. 15:1217–1225. 2012.PubMed/NCBI View Article : Google Scholar

43 

Violi F, Basili S, Berger JS and Hiatt WR: Antiplatelet therapy in peripheral artery disease. Handb Exp Pharmacol. 547–563. 2012.PubMed/NCBI View Article : Google Scholar

44 

Weber R, Brenck J and Diener HC: Antiplatelet therapy in cerebrovascular disorders. Handb Exp Pharmacol. 519–546. 2012.PubMed/NCBI View Article : Google Scholar

45 

Horton S and Augustin S: Activated clotting time (ACT). Methods Mol Biol. 992:155–167. 2013.PubMed/NCBI View Article : Google Scholar

46 

Papayannis AC, Abdel-Karim AR, Mahmood A, Rangan BV, Makke LB, Banerjee S and Brilakis ES: Association of coronary lipid core plaque with intrastent thrombus formation: A near-infrared spectroscopy and optical coherence tomography study. Catheter Cardiovasc Interv. 81:488–493. 2013.PubMed/NCBI View Article : Google Scholar

47 

Lv Y, Ren Y, Sun L, Wang S, Wei M and Jia D: Protective effect of Na(+)/Ca (2+) exchange blocker KB-R7943 on myocardial ischemia-reperfusion injury in hypercholesterolemic rats. Cell Biochem Biophys. 66:357–363. 2013.PubMed/NCBI View Article : Google Scholar

48 

Ueno H and Harrington WF: Temperature-dependence of local melting in the myosin subfragment-2 region of the rigor cross-bridge. J Mol Biol. 190:59–68. 1986.PubMed/NCBI View Article : Google Scholar

49 

Manchikanti L, Falco FJ, Benyamin RM, Caraway DL, Kaye AD, Helm S II, Wargo BW, Hansen H, Parr AT, Singh V, et al: Assessment of bleeding risk of interventional techniques: A best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Pain Physician. 16 (2 Suppl):SE261–SE318. 2013.PubMed/NCBI

50 

Vanstreels L, Molenberghs G and Voigt JU: Secondary stroke prevention: Misguided by guidelines? Acta Cardiol. 67:431–438. 2012.PubMed/NCBI View Article : Google Scholar

51 

Torres-Urrutia C, Guzmán L, Schmeda-Hirschmann G, Moore-Carrasco R, Alarcón M, Astudillo L, Gutierrez M, Carrasco G, Yuri JA, Aranda E and Palomo I: Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagul Fibrinolysis. 22:197–205. 2011.PubMed/NCBI View Article : Google Scholar

52 

Joffs C, Gunasinghe HR, Multani MM, Dorman BH, Kratz JM, Crumbley AJ III, Crawford FA Jr and Spinale FG: Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg. 71:1518–1523. 2001.PubMed/NCBI View Article : Google Scholar

53 

Wang HT, Wang SM, Yun TTS, G. H and Wang ZZ: Effects of sindacom on the expressions of MMP-9 and myocardial ischemia reperfusion injury of rats. J Chin Gerontol. 30:2619–2621. 2010.(In Chinese).

54 

Lee JS, Lee JS, Cha KJ, Kim DE, Lee D, Jung SY, Park ES and Kim IS: Fisetin protects H9c2 cardiomyoblast cells against H2O2-induced apoptosis through Akt and ERK1/2 signaling pathways. Mol Cell Toxicol. 14:183–192. 2018.

55 

Kang KA, Piao MJ, Madduma Hewage SR, Ryu YS, Oh MC, Kwon TK, Chae S and Hyun JW: Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MARK signaling pathway. Tumour Biol. 37:9615–9624. 2016.PubMed/NCBI View Article : Google Scholar

56 

Kim JA, Lee S, Kim DE, Kim M, Kwon BM and Han CH: Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter. Carcinogenesis. 36:696–706. 2015.PubMed/NCBI View Article : Google Scholar

57 

Kang KA, Piao MJ and Hyun JW: Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway. In Vitro Cell Dev Biol Anim. 51:300–309. 2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Long L, Han X, Ma X, Li K, Liu L, Dong J, Qin B, Zhang K, Yang K, Yan H, Yan H, et al: Protective effects of fisetin against myocardial ischemia/reperfusion injury. Exp Ther Med 19: 3177-3188, 2020.
APA
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J. ... Yan, H. (2020). Protective effects of fisetin against myocardial ischemia/reperfusion injury. Experimental and Therapeutic Medicine, 19, 3177-3188. https://doi.org/10.3892/etm.2020.8576
MLA
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J., Qin, B., Zhang, K., Yang, K., Yan, H."Protective effects of fisetin against myocardial ischemia/reperfusion injury". Experimental and Therapeutic Medicine 19.5 (2020): 3177-3188.
Chicago
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J., Qin, B., Zhang, K., Yang, K., Yan, H."Protective effects of fisetin against myocardial ischemia/reperfusion injury". Experimental and Therapeutic Medicine 19, no. 5 (2020): 3177-3188. https://doi.org/10.3892/etm.2020.8576
Copy and paste a formatted citation
x
Spandidos Publications style
Long L, Han X, Ma X, Li K, Liu L, Dong J, Qin B, Zhang K, Yang K, Yan H, Yan H, et al: Protective effects of fisetin against myocardial ischemia/reperfusion injury. Exp Ther Med 19: 3177-3188, 2020.
APA
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J. ... Yan, H. (2020). Protective effects of fisetin against myocardial ischemia/reperfusion injury. Experimental and Therapeutic Medicine, 19, 3177-3188. https://doi.org/10.3892/etm.2020.8576
MLA
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J., Qin, B., Zhang, K., Yang, K., Yan, H."Protective effects of fisetin against myocardial ischemia/reperfusion injury". Experimental and Therapeutic Medicine 19.5 (2020): 3177-3188.
Chicago
Long, L., Han, X., Ma, X., Li, K., Liu, L., Dong, J., Qin, B., Zhang, K., Yang, K., Yan, H."Protective effects of fisetin against myocardial ischemia/reperfusion injury". Experimental and Therapeutic Medicine 19, no. 5 (2020): 3177-3188. https://doi.org/10.3892/etm.2020.8576
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team